These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6137601)

  • 21. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.
    Young RJ; Ewing DJ; Clarke BF
    Diabetes; 1983 Oct; 32(10):938-42. PubMed ID: 6225686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials of sorbinil on nerve function.
    Pfeifer MA
    Metabolism; 1986 Apr; 35(4 Suppl 1):78-82. PubMed ID: 3083211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.
    Judzewitsch RG; Jaspan JB; Polonsky KS; Weinberg CR; Halter JB; Halar E; Pfeifer MA; Vukadinovic C; Bernstein L; Schneider M; Liang KY; Gabbay KH; Rubenstein AH; Porte D
    N Engl J Med; 1983 Jan; 308(3):119-25. PubMed ID: 6401351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent clinical experience with aldose reductase inhibitors.
    Krans HM
    Diabet Med; 1993; 10 Suppl 2():44S-48S. PubMed ID: 8334842
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical experience with sorbinil--an aldose reductase inhibitor.
    Pitts NE; Vreeland F; Shaw GL; Peterson MJ; Mehta DJ; Collier J; Gundersen K
    Metabolism; 1986 Apr; 35(4 Suppl 1):96-100. PubMed ID: 3083213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
    Fagius J; Jameson S
    J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):991-1001. PubMed ID: 6801211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.
    Hotta N; Toyota T; Matsuoka K; Shigeta Y; Kikkawa R; Kaneko T; Takahashi A; Sugimura K; Koike Y; Ishii J; Sakamoto N;
    Diabetes Care; 2001 Oct; 24(10):1776-82. PubMed ID: 11574441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy.
    Pitts NE; Gundersen K; Mehta DJ; Vreeland F; Shaw GL; Peterson MJ; Collier J
    Drugs; 1986; 32 Suppl 2():30-5. PubMed ID: 3098543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial.
    Sundkvist G; Armstrong FM; Bradbury JE; Chaplin C; Ellis SH; Owens DR; Rosén I; Sönksen P
    J Diabetes Complications; 1992; 6(2):123-30. PubMed ID: 1611136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity.
    Sima AA; Prashar A; Nathaniel V; Bril V; Werb MR; Greene DA
    Diabet Med; 1993 Mar; 10(2):115-21. PubMed ID: 8458187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy.
    Boulton AJ; Levin S; Comstock J
    Diabetologia; 1990 Jul; 33(7):431-7. PubMed ID: 2119323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autonomic and peripheral nerve function in early diabetic neuropathy. Possible influence of a novel aldose reductase inhibitor on autonomic function.
    Sundkvist G; Lilja B; Rosén I; Agardh CD
    Acta Med Scand; 1987; 221(5):445-53. PubMed ID: 3111179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurophysiological variables and fibrinolysis in insulin-dependent diabetes treated with an aldose reductase inhibitor or placebo. A double-blind randomized study.
    Jespersen J; Gram J; Christensen JE
    Haemostasis; 1986; 16(6):453-7. PubMed ID: 3108105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial of an aldose reductase inhibitor in diabetic neuropathy.
    Handelsman DJ; Turtle JR
    Diabetes; 1981 Jun; 30(6):459-64. PubMed ID: 6785131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes.
    Malone JI; Lowitt S; Salem AF; Miranda C; Korthals JK; Carver J
    Metabolism; 1996 Jul; 45(7):902-7. PubMed ID: 8692029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report.
    Culebras A; Alió J; Herrera JL; López-Fraile MI
    Arch Neurol; 1981 Feb; 38(2):133-4. PubMed ID: 6781454
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 40. The sorbinil retinopathy trial: neuropathy results. Sorbinil Retinopathy Trial Research Group.
    Neurology; 1993 Jun; 43(6):1141-9. PubMed ID: 8170559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.